These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34210121)

  • 1. Force Field Parameterization for the Description of the Interactions between Hydroxypropyl-β-Cyclodextrin and Proteins.
    Arsiccio A; Rospiccio M; Shea JE; Pisano R
    J Phys Chem B; 2021 Jul; 125(27):7397-7405. PubMed ID: 34210121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of [D-Trp6, Des-Gly10] LHRH ethylamide and hydroxy propyl beta-cyclodextrin (HPbetaCD): thermodynamics of interaction and protection from degradation by alpha-chymotrypsin.
    Koushik KN; Bandi N; Kompella UB
    Pharm Dev Technol; 2001 Nov; 6(4):595-606. PubMed ID: 11775960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weak antibody-cyclodextrin interactions determined by quartz crystal microbalance and dynamic/static light scattering.
    Härtl E; Dixit N; Besheer A; Kalonia D; Winter G
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):781-9. PubMed ID: 23685354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hydroxypropyl beta-cyclodextrin on drug solubility in water-propylene glycol mixtures.
    Chang RK; Shojaei AH
    Drug Dev Ind Pharm; 2004 Mar; 30(3):297-302. PubMed ID: 15109029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
    Mura P; Faucci MT; Bettinetti GP
    Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfisoxazole/cyclodextrin inclusion complex incorporated in electrospun hydroxypropyl cellulose nanofibers as drug delivery system.
    Aytac Z; Sen HS; Durgun E; Uyar T
    Colloids Surf B Biointerfaces; 2015 Apr; 128():331-338. PubMed ID: 25769282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
    Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
    Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of degree of substitution on the hydroxypropyl-β-cyclodextrin complexation with rifampicin in water solution: a molecular simulation.
    Alvira E
    J Mol Model; 2024 Mar; 30(4):113. PubMed ID: 38546892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Cyclodextrins against Interface-Induced Denaturation in Pharmaceutical Formulations: A Molecular Dynamics Approach.
    Rospiccio M; Arsiccio A; Winter G; Pisano R
    Mol Pharm; 2021 Jun; 18(6):2322-2333. PubMed ID: 33999634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of simvastatin into lipid membranes: Why deliver a statin in form of inclusion complex with hydrophilic cyclodextrin.
    Bartkowiak A; Matyszewska D; Krzak A; Zaborowska M; Broniatowski M; Bilewicz R
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111784. PubMed ID: 33984617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion complex formation of steroidal drugs with hydroxypropyl-beta-cyclodextrin studied by charge-transfer chromatography.
    Cserháti T; Forgács E
    J Pharm Biomed Anal; 1998 Oct; 18(1-2):179-85. PubMed ID: 9863956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
    Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
    Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
    Williams RO; Mahaguna V; Sriwongjanya M
    Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theoretical study of structures and charge distributions of 2-, 3- and 6-hydroxypropyl-β-cyclodextrin with different degrees of substitution.
    Alvira E
    J Biomol Struct Dyn; 2023 Dec; 41(20):10582-10590. PubMed ID: 36524475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.
    Joguparthi V; Anderson BD
    Pharm Res; 2008 Nov; 25(11):2505-15. PubMed ID: 18642063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
    Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
    Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-beta-cyclodextrin: selection of meglumine, a polyhydroxy base, as a novel ternary component.
    Basavaraj S; Sihorkar V; Shantha Kumar TR; Sundaramurthi P; Srinivas NR; Venkatesh P; Ramesh M; Kumar Singh S
    Pharm Dev Technol; 2006; 11(4):443-51. PubMed ID: 17101515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.
    Ungaro F; Giovino C; Catanzano O; Miro A; Mele A; Quaglia F; La Rotonda MI
    Int J Pharm; 2011 Feb; 404(1-2):49-56. PubMed ID: 21056648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.